Related Experiment Video
Updated: Jun 27, 2026
04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Orofacial granulomatosis--a 20-year review
B Grave1, M McCullough, D Wiesenfeld
1Oral and Maxillofacial Surgery Unit, The Royal Melbourne Hospital, Melbourne, Australia.
Oral Diseases
|December 17, 2008
Summary
Orofacial granulomatosis (OFG) is a persistent oral swelling. Its cause remains unknown, and treatments are unsatisfactory, highlighting the need for further research into this condition.
Area of Science:
- Oral medicine
- Dermatology
- Gastroenterology
Background:
- Orofacial granulomatosis (OFG) presents as persistent soft tissue enlargement in the oral and maxillofacial region.
- It is characterized by non-caseating granulomatous inflammation.
- OFG diagnosis excludes systemic Crohn's disease (CD) or sarcoidosis.
Purpose of the Study:
- To review the understanding of orofacial granulomatosis (OFG) aetiology, pathogenesis, and treatment.
- To analyze management and outcomes of OFG since its first description in 1985.
- To address the lack of consensus on whether OFG is a distinct disorder or an early sign of CD or sarcoidosis.
Main Methods:
- Extensive literature review.
- Analysis of developments in OFG understanding over 20 years.
- Focus on aetiology, pathogenesis, treatment, management, and outcomes.
Main Results:
- The precise cause of OFG remains unknown, with theories including infection, genetics, and allergy.
- The aetiology and pathogenesis of OFG are not fully understood.
- Clinical outcomes for OFG patients are unpredictable, and current therapies are unsatisfactory.
Conclusions:
- There is no consensus on whether OFG is a distinct clinical entity or an initial presentation of Crohn's disease or sarcoidosis.
- Further research is needed to elucidate the cause and improve treatment for OFG.
- Regular clinical review is essential for OFG patients to monitor for systemic involvement.